OUR MISSION
We develop evidence-based imaging solutions to non-invasively diagnose high-risk
atherosclerotic plaque before rupture and to enable effective stroke preventive treatments.
We are achieving our mission with innovative and validated
products, an experienced team, application-focused design, quality execution, and academic, clinical, and business
partnerships.
VPDiagnostics currently offers the FDA cleared software product: MRI-PlaqueViewTM.
Analysis of plaque characteristics by MRI-PlaqueViewTM can assist clinicians in making management decisions based upon scientific literature. It can also assist clinicains in planning for the most suitable treatment.
It also enables faster and more reliably quantitative detection of disease progression in medical research
and drug development. VPDiagnostics is also leading an NIH-sponsored multi-center prospective
clinical trial to evaluate a new diagnostic utility for use with MRI-PlaqueViewTM that will enable the prediction of future
risk of stroke and related neurological complications based on plaque characteristics.
| |
| |
|
|